Follow
Matthew Novak
Matthew Novak
R&D Lead, Abbott Diabetes Care
Verified email at abbott.com - Homepage
Title
Cited by
Cited by
Year
Modeling the relative impact of capsular tissue effects on implanted glucose sensor time lag and signal attenuation
MT Novak, F Yuan, WM Reichert
Analytical and bioanalytical chemistry 398, 1695-1705, 2010
772010
Systems, devices, and methods relating to medication dose guidance
GA Hayter, A Bhattacharya, ES Budiman, MT Novak, T Jin, MB Taub, ...
US Patent App. 16/944,736, 2021
302021
Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials
MT Novak, JD Bryers, WM Reichert
Biomaterials 30 (11), 1989-2005, 2009
252009
Response of monocytes exposed to phagocytosable particles and discs of comparable surface roughness
DH Kim, MT Novak, J Wilkins, M Kim, A Sawyer, WM Reichert
Biomaterials 28 (29), 4231-4239, 2007
252007
Predicting glucose sensor behavior in blood using transport modeling: relative impacts of protein biofouling and cellular metabolic effects.
MT Novak, F Yuan, WM Reichert
Journal of diabetes science and technology 7 (6), 1547-1560, 2013
222013
Diagnostic tools and technologies for infectious and non-communicable diseases in low-and-middle-income countries
MT Novak, CN Kotanen, S Carrara, A Guiseppi-Elie, FG Moussy
Health and Technology 3, 271-281, 2013
202013
Modeling the physiological factors affecting glucose sensor function in vivo
MT Novak, WM Reichert
Journal of Diabetes Science and Technology 9 (5), 993-998, 2015
182015
Macrophage embedded fibrin gels: An in vitro platform for assessing inflammation effects on implantable glucose sensors
MT Novak, F Yuan, WM Reichert
Biomaterials 35 (36), 9563-9572, 2014
172014
Dynamic Seeding of Perfusing Human Umbilical Vein Endothelial Cells (HUVECs) onto Dual-Function Cell Adhesion Ligands: Arg-Gly-Asp (RGD)− Streptavidin and Biotinylated Fibronectin
CC Anamelechi, EC Clermont, MT Novak, WM Reichert
Langmuir 25 (10), 5725-5730, 2009
102009
Modeling the Relative Effects of Biofouling, Fibrous Encapsulation and Microvessel Density on Implanted Glucose Sensor Performance
MT Novak, F Yuan, WM Reichert
Biophysical Journal 98 (3), 407a, 2010
22010
Systems and methods for diabetes management
PA Kumar, K Hilton, JR Floeh, AM Revoltar, LC Swinehart, ...
US Patent App. 17/725,063, 2022
12022
Systems, devices, and methods relating to medication dose guidance
GA Hayter, A Bhattacharya, ES Budiman, MT Novak, T Jin, MB Taub, ...
US Patent App. 17/591,229, 2022
12022
Impact of insulin excipients and infusion set wear time on insulin PK/PD
R Pettis, L Hull, M Novak, A Harvey, D Morel, D Sutter, M Hompesch, ...
DIABETES TECHNOLOGY & THERAPEUTICS 22, A193-A193, 2020
12020
Subcutaneous Bolus Administration of Meta-Cresol Decreases Insulin Absorption in a Swine Model
MT Novak, K Riley, J Alarcon, A Harvey, R Pettis
Diabetes Technology and Therapeutics 20 (S1), A140, 2018
12018
Systems and methods for diabetes management
ES Budiman, MT Novak, GA Hayter
US Patent App. 18/226,550, 2024
2024
Filter for reducing phenolic compounds from insulin and related infusion and injection devices
M Novak, AJ Harvey, DB Sherman, RJ Radford, J Alarcon, RJ Pettis, ...
US Patent 11,672,907, 2023
2023
79-LB: The Effects of Glucose Reporting Tools on Therapeutic Decision Making—A Comparative Reading Study with Primary Care Providers
MT Novak, G Hayter, E Wright, K Midyett, H Wolpert, N Virdi
Diabetes 71 (Supplement_1), 2022
2022
Delivery device and adsorbent
M Novak, E Mainz, C Rini, B Roberts
US Patent App. 17/050,321, 2021
2021
Systems, devices, and methods relating to medication dose guidance
GA Hayter, A Bhattacharya, ES Budiman, MT Novak, T Jin, MB Taub, ...
US Patent US20210050085A1, 2021
2021
Delivery device and adsorbent
M Novak, E Mainz, C Rini, B Robert
WO Patent App. 2019209644A1, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20